Home › NDC Lookup › RxCUI directory › RxCUI 1790095

Doxorubicin hydrochloride 50 MG Injection — RxCUI 1790095

Name: Doxorubicin hydrochloride 50 MG Injection (RxCUI 1790095)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1790095 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1790095

Official nameDoxorubicin hydrochloride 50 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asDOXOrubicin HCl 50 MG Injection

FDA products mapped5

Package NDCs mapped5

Reported Medicaid activity (SDUD)14 prescriptions · 1 state & territory Medicaid programs · latest period Q3 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Doxorubicin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Doxorubicin is well-known for its potential to damage the heart muscle over time — a condition called cardiomyopathy. The higher the total amount you receive over your lifetime, th...
Why is my doctor monitoring my heart so closely while I'm on this drug?
It's a real but uncommon risk. A small number of people who receive doxorubicin — especially when combined with other DNA-damaging chemotherapy drugs or radiation — have gone on to...
I've heard this drug can cause leukemia later. Should I be worried?

📖 Read our full Doxorubicin guide →

🕸️ Concept Web — How Doxorubicin hydrochloride 50 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Doxorubicin hydrochloride 50 MG Injection RxCUI 1790095 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Doxorubicin 3639 IN
- Doxorubicin hydrochloride 142433 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Adriamycin 42512 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Doxorubicin Injection 1790094 SCDF
- Doxorubicin hydrochloride Injection 2645409 SCDFP
- Doxorubicin Injectable Product 1160774 SCDG
- Doxorubicin hydrochloride Injectable Product 2662060 SCDGP
- Doxorubicin Injection [Adriamycin] 1799303 SBDF
- Doxorubicin hydrochloride Injection [Adriamycin] 2657399 SBDFP
- Adriamycin Injectable Product 1799304 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Doxorubicin hydrochloride 50 MG 1790093 SCDC
- Doxorubicin hydrochloride 50 MG Injection [Adriamycin] 2001100 SBD
- Doxorubicin hydrochloride 50 MG [Adriamycin] 2001099 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Doxorubicin hydrochloride 50 MG SCDC · 1790093
Doxorubicin Injection SCDF · 1790094
Doxorubicin hydrochloride Injection SCDFP · 2645409
Doxorubicin Injectable Product SCDG · 1160774
Doxorubicin hydrochloride Injectable Product SCDGP · 2662060

Brand-Name Concepts

Doxorubicin hydrochloride 50 MG Injection [Adriamycin] SBD · 2001100
Doxorubicin hydrochloride 50 MG [Adriamycin] SBDC · 2001099
Doxorubicin Injection [Adriamycin] SBDF · 1799303
Doxorubicin hydrochloride Injection [Adriamycin] SBDFP · 2657399
Adriamycin Injectable Product SBDG · 1799304
Adriamycin BN · 42512

📦 FDA Products & Package NDCs

5 products · 5 package NDCs

5 package NDCs map to RxCUI 1790095 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9092-01	1 VIAL in 1 BOX (0143-9092-01) / 5 mL in 1 VIAL	Doxorubicin Hydrochloride	Hikma Pharmaceuticals USA Inc.	2018-01-19
00143-9093-01	1 VIAL in 1 BOX (0143-9093-01) / 25 mL in 1 VIAL	Doxorubicin Hydrochloride	Hikma Pharmaceuticals USA Inc.	2018-01-19
67457-0436-50	1 VIAL in 1 CARTON (67457-436-50) / 25 mL in 1 VIAL	Doxorubicin Hydrochloride	Mylan Institutional LLC	2014-02-27
70121-1218-07	10 CARTON in 1 CARTON (70121-1218-7) / 1 VIAL in 1 CARTON (...	Doxorubicin Hydrochloride	Amneal Pharmaceuticals LLC	2017-02-17
70121-1219-01	1 VIAL in 1 CARTON (70121-1219-1) / 25 mL in 1 VIAL	Doxorubicin Hydrochloride	Amneal Pharmaceuticals LLC	2017-02-17

Observed labelers: Amneal Pharmaceuticals LLC (2) · Hikma Pharmaceuticals USA Inc. (2) · Mylan Institutional LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9000	Doxorubicin hcl injection	3	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.